83 related articles for article (PubMed ID: 19524501)
21. The retinoblastoma tumour suppressor in development and cancer.
Classon M; Harlow E
Nat Rev Cancer; 2002 Dec; 2(12):910-7. PubMed ID: 12459729
[TBL] [Abstract][Full Text] [Related]
22. Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.
Zhang YF; Zhang BC; Zhang AR; Wu TT; Liu J; Yu LF; Wang WX; Gao JF; Fang DC; Rao ZG
Oncol Rep; 2013 Oct; 30(4):1989-95. PubMed ID: 23933826
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of the p53 pathway in retinoblastoma.
Laurie NA; Donovan SL; Shih CS; Zhang J; Mills N; Fuller C; Teunisse A; Lam S; Ramos Y; Mohan A; Johnson D; Wilson M; Rodriguez-Galindo C; Quarto M; Francoz S; Mendrysa SM; Guy RK; Marine JC; Jochemsen AG; Dyer MA
Nature; 2006 Nov; 444(7115):61-6. PubMed ID: 17080083
[TBL] [Abstract][Full Text] [Related]
24. Id-1 promotes proliferation of p53-deficient esophageal cancer cells.
Hui CM; Cheung PY; Ling MT; Tsao SW; Wang X; Wong YC; Cheung AL
Int J Cancer; 2006 Aug; 119(3):508-14. PubMed ID: 16506209
[TBL] [Abstract][Full Text] [Related]
25. FGF19 exhibits neuroprotective effects on adult mammalian photoreceptors in vitro.
Siffroi-Fernandez S; Felder-Schmittbuhl MP; Khanna H; Swaroop A; Hicks D
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1696-704. PubMed ID: 18385093
[TBL] [Abstract][Full Text] [Related]
26. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the Jagged/Notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β‑catenin signaling pathways.
Xiao W; Chen X; He M
Mol Med Rep; 2014 Jul; 10(1):453-8. PubMed ID: 24805975
[TBL] [Abstract][Full Text] [Related]
28. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
Kong Y; Lu ZL; Wang JJ; Zhou R; Guo J; Liu J; Sun HL; Wang H; Song W; Yang J; Xu HX
Oncol Rep; 2016 Sep; 36(3):1447-56. PubMed ID: 27432230
[TBL] [Abstract][Full Text] [Related]
29. Retinoid x receptor gamma is implicated in docosahexaenoic acid modulation of despair behaviors and working memory in mice.
Wietrzych-Schindler M; Szyszka-Niagolov M; Ohta K; Endo Y; Pérez E; de Lera AR; Chambon P; Krezel W
Biol Psychiatry; 2011 Apr; 69(8):788-94. PubMed ID: 21334601
[TBL] [Abstract][Full Text] [Related]
30. MiR-204, down-regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP-9.
Wu X; Zeng Y; Wu S; Zhong J; Wang Y; Xu J
FEBS Lett; 2015 Feb; 589(5):645-50. PubMed ID: 25647033
[TBL] [Abstract][Full Text] [Related]
31. Tissue factor regulates tumor angiogenesis of retinoblastoma via the extracellular signal-regulated kinase pathway.
Song HB; Park KD; Kim JH; Kim DH; Yu YS; Kim JH
Oncol Rep; 2012 Dec; 28(6):2057-62. PubMed ID: 23007470
[TBL] [Abstract][Full Text] [Related]
32. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K-Akt-MDM2 signaling suppression.
Dung TD; Day CH; Binh TV; Lin CH; Hsu HH; Su CC; Lin YM; Tsai FJ; Kuo WW; Chen LM; Huang CY
Food Chem Toxicol; 2012 May; 50(5):1802-10. PubMed ID: 22289577
[TBL] [Abstract][Full Text] [Related]
33. Constitutively active Akt contributes to vincristine resistance in human retinoblastoma cells.
Zhang H; Li B; Bai SW; Wang HJ
Cancer Invest; 2010 Feb; 28(2):156-65. PubMed ID: 19968493
[TBL] [Abstract][Full Text] [Related]
34. PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.
Papi A; Tatenhorst L; Terwel D; Hermes M; Kummer MP; Orlandi M; Heneka MT
J Neurochem; 2009 Jun; 109(6):1779-90. PubMed ID: 19457135
[TBL] [Abstract][Full Text] [Related]
35. Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
Merk D
Future Med Chem; 2015; 7(18):2411-3. PubMed ID: 26653291
[No Abstract] [Full Text] [Related]
36. KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction.
Okamoto K; Kitabayashi I; Taya Y
Biochem Biophys Res Commun; 2006 Dec; 351(1):216-22. PubMed ID: 17056014
[TBL] [Abstract][Full Text] [Related]
37. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
[TBL] [Abstract][Full Text] [Related]
38. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
[TBL] [Abstract][Full Text] [Related]
39. Nutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation.
Walsh EM; Niu M; Bergholz J; Xiao ZX
Biochem Biophys Res Commun; 2015 May; 461(2):293-9. PubMed ID: 25871794
[TBL] [Abstract][Full Text] [Related]
40. Met acts on Mdm2 via mTOR to signal cell survival during development.
Moumen A; Patané S; Porras A; Dono R; Maina F
Development; 2007 Apr; 134(7):1443-51. PubMed ID: 17329361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
